1-3 of 3
SH Nantel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy

DE Reece, MJ Barnett, JD Shepherd, DE Hogge, RJ Klasa, SH Nantel, HJ Sutherland, HG Klingemann, RN Fairey, NJ Voss
Journal: Blood
Blood (1995) 86 (2): 451–456.
https://doi.org/10.1182/blood.V86.2.451.bloodjournal862451
Published: 1995
Journal Articles

Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study [see comments]

MJ Barnett, CJ Eaves, GL Phillips, RD Gascoyne, DE Hogge, DE Horsman, RK Humphries, HG Klingemann, PM Lansdorp, SH Nantel
Journal: Blood
Blood (1994) 84 (3): 724–732.
https://doi.org/10.1182/blood.V84.3.724.724
Published: 1994
Journal Articles

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

DE Reece, JM Connors, JJ Spinelli, MJ Barnett, RN Fairey, HG Klingemann, SH Nantel, S O'Reilly, JD Shepherd, HJ Sutherland
Journal: Blood
Blood (1994) 83 (5): 1193–1199.
https://doi.org/10.1182/blood.V83.5.1193.1193
Published: 1994